{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:50:05Z","timestamp":1768251005234,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23659384"],"award-info":[{"award-number":["23659384"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23659460"],"award-info":[{"award-number":["23659460"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24659352"],"award-info":[{"award-number":["24659352"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22390180"],"award-info":[{"award-number":["22390180"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.neulet.2014.10.039","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T08:29:17Z","timestamp":1414830557000},"page":"276-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats"],"prefix":"10.1016","volume":"584","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0558-2890","authenticated-orcid":false,"given":"Syuuichirou","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Iwahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Hisahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Honmou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Shimohama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2014.10.039_bib0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mds.870130205","article-title":"Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease","volume":"13","author":"Banati","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2014.10.039_bib0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3727\/096368912X657404","article-title":"Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis","volume":"22","author":"Cobo","year":"2013","journal-title":"Cell Transplant."},{"key":"10.1016\/j.neulet.2014.10.039_bib0015","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1096\/fj.02-0799fje","article-title":"Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation","volume":"17","author":"Delgado","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.neulet.2014.10.039_bib0020","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1172\/JCI200420935","article-title":"Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation","volume":"113","author":"Dezawa","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neulet.2014.10.039_bib0025","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0196-9781(03)00059-7","article-title":"Passage of vasoactive intestinal peptide across the blood-brain barrier","volume":"24","author":"Dogrukol-Ak","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.neulet.2014.10.039_bib0030","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","article-title":"Tyrosine hydroxylase phosphorylation: regulation and consequences","volume":"91","author":"Dunkley","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2014.10.039_bib0035","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3171\/jns.2003.98.5.1078","article-title":"Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage","volume":"98","author":"Hebb","year":"2003","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neulet.2014.10.039_bib0040","first-page":"951709","article-title":"Toxin-induced and genetic animal models of Parkinson's disease","volume":"2011","author":"Hisahara","year":"2010","journal-title":"Parkinson's Dis."},{"key":"10.1016\/j.neulet.2014.10.039_bib0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","article-title":"Nitric oxide synthase and neuronal vulnerability in Parkinson's disease","volume":"72","author":"Hunot","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2014.10.039_bib0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jnr.23128","article-title":"Therapeutic effects of human mesenchymal and hematopoietic stem cells on rotenone-treated parkinsonian mice","volume":"91","author":"Inden","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2014.10.039_bib0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1789.2006.00688.x","article-title":"Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease","volume":"26","author":"Kim","year":"2006","journal-title":"Neuropathology"},{"key":"10.1016\/j.neulet.2014.10.039_bib0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/glia.20731","article-title":"Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action","volume":"57","author":"Kim","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.neulet.2014.10.039_bib0065","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1471-4159.2009.06268.x","article-title":"Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo","volume":"110","author":"Lanza","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2014.10.039_bib0070","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2014.10.039_bib0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1471-4159.2008.05589.x","article-title":"Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease","volume":"107","author":"Park","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2014.10.039_bib0080","series-title":"The Rat Brain in Streotaxic Coordinates","author":"Paxinos","year":"2009"},{"key":"10.1016\/j.neulet.2014.10.039_bib0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tips.2007.03.001","article-title":"Nicotine neuroprotection against nigrostriatal damage: importance of the animal model","volume":"28","author":"Quik","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neulet.2014.10.039_bib0090","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1634\/stemcells.2006-0386","article-title":"Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease","volume":"25","author":"Rodriguez-Gomez","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.neulet.2014.10.039_bib0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2014.10.039_bib0100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1471-4914(03)00117-5","article-title":"Disease model: Parkinson's disease","volume":"9","author":"Shimohama","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neulet.2014.10.039_bib0130","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jnr.23160","article-title":"3-[(2,4-Dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through alpha7 nicotinic acetylcholine receptor stimulation in rats","volume":"91","author":"Suzuki","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2014.10.039_bib0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2202-11-52","article-title":"Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neulet.2014.10.039_bib0115","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.nbd.2009.02.015","article-title":"Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex","volume":"34","author":"Wirenfeldt","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2014.10.039_bib0120","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neures.2008.09.003","article-title":"Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model","volume":"62","author":"Yanagida","year":"2008","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neulet.2014.10.039_bib0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2009.11.012","article-title":"Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia","volume":"1310","author":"Zheng","year":"2010","journal-title":"Brain Res."}],"updated-by":[{"DOI":"10.1016\/j.neulet.2014.12.023","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T00:00:00Z","timestamp":1423094400000}}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014008519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014008519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:18:24Z","timestamp":1759609104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394014008519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":25,"alternative-id":["S0304394014008519"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2014.10.039","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2014.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}